Contribution: Industrial Research Assistance Program – Contributions to Firms
Pathway Rx Inc.
$463,000.00
Medical applications of cannabis and fungal extracts
EF 2021-22 · 2021-11-01
Résumé
Development of novel botanical and fungal extracts for treatment inflammation in various human tissues. Using a combination of in vitro and in vivo assays, including single cell cultures, 3D tissues and mice/rat models, Pathway will develop formulations for treatment and prevention of inflammation-related conditions.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Calgary|Calgary, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
725412480
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2021-11-01 | 2021-22 | $228,000.00 |
| 1 | 2021-11-01 | 2021-22 | $378,000.00 |
| 2 | 2021-11-01 | 2021-22 | $463,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 152 days. The total amended value is 85,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 152 jours. La valeur totale des modifications est de 85 000 dollars.
Agreement End Date
2024-02-29
Agreement Number
981927
Agreement Start Date
2021-11-01
Agreement Title
Medical applications of cannabis and fungal extracts
Agreement Title (French)
Applications médicales d'extraits de cannabis et de champignons
Agreement Type
Contribution
Agreement Value
$463,000.00
Amendment Date
2023-09-05
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of novel botanical and fungal extracts for treatment inflammation in various human tissues. Using a combination of in vitro and in vivo assays, including single cell cultures, 3D tissues and mice/rat models, Pathway will develop formulations for treatment and prevention of inflammation-related conditions.
Description (French)
Développement de nouveaux extraits botaniques et fongiques pour le traitement de l'inflammation dans divers tissus humains. En utilisant une combinaison d'essais in vitro et in vivo, y compris des cultures de cellules uniques, des tissus en 3D et des modèles souris/rats, Pathway développera des formulations pour le traitement et la prévention des conditions liées à l'inflammation.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Signal Hill
Federal Riding (French)
Calgary Signal Hill
Federal Riding Number
48012
NAICS Code
32541
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
725412480
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Pathway Rx Inc.
Recipient Postal Code
T3H 4Z2
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2021-2022-Q3-981927
